Literature DB >> 26884667

Esophageal Cancer with a Synchronous Multiple Carcinoid of the Duodenal Bulb.

Xu Feng Deng1, Quan Xing Liu1, Bin Hou1, Jia Xin Min1, Ji Gang Dai1.   

Abstract

Carcinoid tumors of the duodenum are relatively rare. Although they were considered benign lesions, they are now classified malignant, occasionally with poor prognosis. We report a case of esophageal cancer with a synchronous multiple carcinoid of the duodenal bulb. An upper endoscopy visualized with esophageal scan disclosed a stenotic lesion in the lower esophagus and revealed multiple 4--5-mm-diameter masses which were on the fore wall of the duodenal bulb. The postoperative pathology report confirmed the diagnosis of esophageal squamous cancer and duodenal bulb carcinoid.

Entities:  

Keywords:  Duodenal bulb carcinoid; Esophageal cancer; Synchronous cancers

Year:  2015        PMID: 26884667      PMCID: PMC4744219          DOI: 10.1007/s12262-015-1338-0

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  4 in total

Review 1.  Concurrent colonic adenocarcinoma and two ileal carcinoids in a 72-year-old male.

Authors:  V Tse; A Lochhead; W Adams; D Tindal
Journal:  Aust N Z J Surg       Date:  1997-10

Review 2.  [Neuroendocrine tumours of the gastrointestinal tract].

Authors:  U Plöckinger; B Wiedenmann
Journal:  Z Gastroenterol       Date:  2004-06       Impact factor: 2.000

3.  The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies.

Authors:  J T Gerstle; G L Kauffman; W A Koltun
Journal:  J Am Coll Surg       Date:  1995-04       Impact factor: 6.113

4.  [Digestive carcinoids and synchronous malignant tumors].

Authors:  M Berner
Journal:  Helv Chir Acta       Date:  1993-06
  4 in total
  1 in total

1.  Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?

Authors:  Rafael Parra-Medina; Paula Moreno-Lucero; Julian Jimenez-Moreno; Alejandra María Parra-Morales; Alfredo Romero-Rojas
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.